PEAK1 Promotes Invasion and Metastasis and Confers Drug Resistance in Breast Cancer

The authors investigated pseudopodium-enriched atypical kinase 1 (PEAK1) expression in breast cancer and its role in breast cancer cells in vitro and in vivo and analyzed the relationship with clinicopathological status and chemotherapy resistance.